Serum cystatin C as an early marker of Acute Kidney Injury in elderly patients after surgery for femur fracture. An observational study
Open Access
- 1 January 2018
- journal article
- Published by Peertechz Publications Private Limited in Archives of Renal Diseases and Management
- Vol. 4 (1), 001-007
- https://doi.org/10.17352/2455-5495.000031
Abstract
Acute kidney injury (AKI) is prevalent in hospitalized patients, primarily in patients undergoing major surgical procedures.Keywords
This publication has 44 references indexed in Scilit:
- World Incidence of AKIClinical Journal of the American Society of Nephrology, 2013
- Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysisAmerican Journal of Kidney Diseases, 2011
- Oliguria as predictive biomarker of acute kidney injury in critically ill patientsCritical Care, 2011
- Cystatin C in acute kidney injuryCurrent Opinion in Critical Care, 2010
- Cystatin C is not a better estimator of GFR than plasma creatinine in the general populationKidney International, 2010
- Plasma Cystatin C and Acute Kidney Injury after Cardiopulmonary BypassClinical Journal of the American Society of Nephrology, 2010
- A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patientsNephrology Dialysis Transplantation, 2008
- Cystatin C: current position and future prospectscclm, 2008
- Early detection of acute renal failure by serum cystatin CKidney International, 2004
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002